12.01.2018 | Letter to the Editor
Comment on a meta-analysis evaluating the cardiac toxicity of lapatinib in patients with breast cancer and other HER2-positive cancers
Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2018
Einloggen, um Zugang zu erhalten